Fig. 3
From: Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
Reprinted with permission [58]. Copyright 2022, Wiley-VCH GmbH.
 A Schematic illustration of the biological mechanism of Z@M-R. B Z@M-R promoting PD-L1 ubiquitination in A549 cells. C Immunofluorescence images of β3-int-overexpressing A549 cells and activated CD8+ T cells co-culture systems. D Quantitative analysis of CD4+ and CD8+ T cells in tumor tissues with different treatments.